Ketamine Adverse Reaction Clinical Trial
Official title:
Randomized Control Study Evaluating Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)
This is a study evaluating the usage of Ketamine as sedative agent in ERCP. The usage of Ketamine will be compared to the standard sedation in our center, which is Midazolam in combination with Pethidine as analgesia.
This is a double blinded study whereby both the surgeons and patients are blinded from the sedative agent used. Patients admitted to UKMMC requiring ERCP will randomized into 2 groups after evaluating the inclusion and exclusion criteria. Patients will be divided into two arms, Midazolam and Ketamine group respectively. Before the initiation of the the scope, patient would be given specified dose of sedation accordingly. All the parameters and outcome would be measured during and after the procedure. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03067974 -
Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study
|
Early Phase 1 | |
| Completed |
NCT04701008 -
Efficacy of Ketamine in Post Anesthesia Recovery Room
|
||
| Completed |
NCT00486902 -
Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?
|
N/A | |
| Completed |
NCT03979105 -
Cardiovascular Safety After Continuous Ketamine Infusion
|
||
| Completed |
NCT03525912 -
Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions
|
N/A |